Enviar artigo por via de e-mail Synthesis and Biological Activity of 2-amino-1-aryl-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-N-(thiazol-5-yl)-4,5-dihydro-1h-pyrrole-3-carboxamides
- Autores: Zykova S.1, Igidov N.2, Zakhmatov A.2, Kiselev M.2, Galembikova A.3, Khusnutdinov R.3, Dunaev P.3, Boichuk S.3, Chernov I.4, Rodin I.5
-
Afiliações:
- Perm Federal Penitentiary Service Institute
- Perm State Pharmaceutical Academy
- Kazan State Medical University
- Research Institute of Chemistry, N. I. Lobachevsky State University of Nizhny Novgorod
- I. T. Trubilin Kuban State Agrarian University
- Edição: Volume 52, Nº 3 (2018)
- Páginas: 198-204
- Seção: Search for New Drugs
- URL: https://journals.rcsi.science/0091-150X/article/view/245076
- DOI: https://doi.org/10.1007/s11094-018-1790-9
- ID: 245076
Citar
Acesso aberto
Acesso está concedido
Somente assinantes
Resumo
A series of new 2-aminopyrrole derivatives [2-amino-1-aryl-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-N-(thiazol-5-yl)-4,5-dihydro-1H-pyrrole-3-carboxamides IIa-h] were synthesized via the reaction of 4-arylamino-2-tert-butyl-2,5-dihydro-5-oxofuran-2-ylacetates (Ia-h) with 2-cyano-N-(thiazol-2-yl)acetamide in the presence of Et3N. Studies of the biological activity of the synthesized compounds found that they possessed low toxicity and that 2-amino-1-(2-bromophenyl)-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-N-(thiazol-5-yl)-4,5-dihydro-1H-pyrrole-3-carboxamide (IIb) and 2-amino-1-(2,4-dichlorophenyl)-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-N-(thiazol-5-yl)-4,5-dihydro-1H-pyrrole-3-carboxamide (IIg) exhibited radical-binding activity greater than that of trolox and cytotoxic activity against gastrointestinal stromal tumor (GIST) cells, including those resistant to the target drug imatinib (Glivec). The cytotoxic activity of the synthesized compounds was comparable with that of doxorubicin chemotherapeutics and exceeded significantly those of etoposide, paclitaxel, and hydroxyurea. Apossible molecular mechanism of action of the synthesized compounds might be their ability to disrupt cell division and induce selective accumulation of M-phase cells with subsequent death by a mitotic catastrophe pathway.
Sobre autores
S. Zykova
Perm Federal Penitentiary Service Institute
Autor responsável pela correspondência
Email: zykova.sv@rambler.ru
Rússia, 125 Karpinskogo St., Perm, 614012
N. Igidov
Perm State Pharmaceutical Academy
Email: zykova.sv@rambler.ru
Rússia, 2 Polevaya St., Perm, 614099
A. Zakhmatov
Perm State Pharmaceutical Academy
Email: zykova.sv@rambler.ru
Rússia, 2 Polevaya St., Perm, 614099
M. Kiselev
Perm State Pharmaceutical Academy
Email: zykova.sv@rambler.ru
Rússia, 2 Polevaya St., Perm, 614099
A. Galembikova
Kazan State Medical University
Email: zykova.sv@rambler.ru
Rússia, 49 Butlerova St., Kazan, Tatarstan, 420012
R. Khusnutdinov
Kazan State Medical University
Email: zykova.sv@rambler.ru
Rússia, 49 Butlerova St., Kazan, Tatarstan, 420012
P. Dunaev
Kazan State Medical University
Email: zykova.sv@rambler.ru
Rússia, 49 Butlerova St., Kazan, Tatarstan, 420012
S. Boichuk
Kazan State Medical University
Email: zykova.sv@rambler.ru
Rússia, 49 Butlerova St., Kazan, Tatarstan, 420012
I. Chernov
Research Institute of Chemistry, N. I. Lobachevsky State University of Nizhny Novgorod
Email: zykova.sv@rambler.ru
Rússia, 23/5 Prosp. Gagarina, Nizhny Novgorod, 603950
I. Rodin
I. T. Trubilin Kuban State Agrarian University
Email: zykova.sv@rambler.ru
Rússia, 13 Kalinina St, Krasnodar, 350044
